Menactra Vaccine is used to prevent meningococcal disease. This is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C,Y and W-135. It is approved for use in individuals 9 months through 55 years of age.
Menactra Vaccine is given by a healthcare professional and should not be self-administered. It is important to receive all the doses of the vaccine to be effective. A single booster dose may be given to individuals 15 through 55 years of age at continued risk for meningococcal disease, if at least 4 to 6 years have elapsed since the prior dose. Do not administer this product intravenously, subcutaneously, or intradermally.
Some common side effects of this medicine include injection site reactions (such as pain, swelling, redness), irritability, loss of appetite, sleepiness, headache, nausea, vomiting, and diarrhea. If these side effects do not go away with time or get worse, let the doctor know. The doctor may help with ways to reduce or prevent these symptoms.
To make sure the vaccine is safe, before receiving the vaccine, it is important to let the doctor know if you have any other illnesses. You should also tell the doctor about all the medicines you are taking. Pregnant and breastfeeding mothers should consult and seek advice from their doctor before receiving the vaccine.
Prevention of Meningococcal disease
Your doctor or nurse will guide you how to use this medicine.
Menactra Vaccine contains Meningococcal Polysaccharides of serogroups A, C, Y, and W-135 antigens. It also contains diphtheria toxoid protein, that acts as a carrier for the individual serogroup antigens. This vaccine helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body’s immune system to produce antibodies (proteins) to protect against any future infections.
Information not available at the moment. Please check back later.
Menactra Vaccine is used for active immunization to prevent meningococcal disease in individuals 9 months through 55 years of age.
In children 9 through 23 months of age, Menactra Vaccine is given as a 2-dose series at least three months apart.
In individuals 2 through 55 years of age, it is given as a single dose.
Information not available at the moment. Please check back later.
In Prevention of Meningococcal disease
Meningococcal disease is a serious bacterial infection of the lining of the brain and spinal cord. It spreads through close contact with an infected person. Although this infection can occur in people of any age group, it is more common in children and teens. Menactra Vaccine helps prevent Meningococcal disease. It helps the immune system to produce antibodies to fight against meningococcal infection. It is advisable to consult your doctor for complete information regarding vaccination schedules.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Diarrhea
Vomiting
Nausea
Headache
Sleepiness
Loss of appetite
Irritability
Injection site reactions (pain, swelling, redness)
Alcohol:CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Menactra Vaccine. Please consult your doctor.
Pregnancy:CONSULT YOUR DOCTOR
Menactra Vaccine may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding:CONSULT YOUR DOCTOR
Information regarding the use of Menactra Vaccine during breastfeeding is not available. Please consult your doctor.
Driving:CONSULT YOUR DOCTOR
It is not known whether Menactra Vaccine alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney:CONSULT YOUR DOCTOR
There is limited information available on the use of Menactra Vaccine in patients with kidney disease. Please consult your doctor.
Liver:CONSULT YOUR DOCTOR
There is limited information available on the use of Menactra Vaccine in patients with liver disease. Please consult your doctor.
MeningococcalPolysaccharide Diphtheria Toxoid Conjugate Vaccine. Swiftwater, PA: Sanofi Pasteur Inc.; 2019. view
Independent Platform: MedbeW.com is an independent aggregator. We are not affiliated with the manufacturer. Brand names are property of their respective owners and used here solely for identification.
Procurement & Availability: We do not store all the products listed on this website. This product will be procured from licensed distributors subject to availability. MedbeW acts as a facilitator to procure authentic medicines for you.
We would like to send you discount and latest offers .
